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Hospital, Perth, WA, AustraliaAbstractTyping of healthcare-associated methicillin-resistant Staphylococcus aureus (MRSA) from Australia in the 1970s revealed a novel clone,
ST2249-MRSA-III (CC45), present from 1973 to 1979. This clone was present before the Australian epidemic caused by the recombinant
clone, ST239-MRSA-III. This study aimed to characterize the genome of ST2249-MRSA-III to establish its relationship to other MRSA
clones. DNA microarray analysis was conducted and a draft genome sequence of ST2249 was obtained. The recombinant structure of
the ST2249 genome was revealed by comparisons to publicly available ST239 and ST45 genomes. Microarray analysis of genomic DNA of
13 ST2249 isolates showed gross similarities with the ST239 chromosome in a segment around the origin of replication and with ST45
for the remainder of the chromosome. Recombination breakpoints were precisely determined by the changing pattern of nucleotide
polymorphisms in the genome sequence of ST2249 isolate SK1585 compared with ST239 and ST45. One breakpoint was identiﬁed to
the right of oriC, between sites 1014 and 1065 of the gene D484_00045. Another was identiﬁed to the left of oriC, between sites 1185
and 1248 of D484_01632. These results indicate that ST2249 inherited approximately 35.3% of its chromosome from an ST239-like
parent and 64.7% from an ST45-like parent. ST2249-MRSA-III resulted from a major recombination between parents that resemble
ST239 and ST45. Although only limited Australian archival material is available, the oldest extant isolate of ST2249 predates the oldest
Australian isolate of ST239 by 3 years. It is therefore plausible that these two recombinant clones were introduced into Australia separately.
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Methicillin-resistant Staphylococcus aureus (MRSA) ﬁrst appeared
in Australia in 1965 in hospitals in Sydney [1] and Melbourne [2].Microbiol Infect 2015; 21: 444–450
nical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infect
p://dx.doi.org/10.1016/j.cmi.2014.12.018The responsible clone, ST250-MRSA-I by multilocus sequence
typing (MLST) and SCCmec typing, caused epidemics in
numerous countries in the ﬁrst global wave of MRSA [3,4].
Contemporary phage typing and phenotypic data suggest that
ST250-MRSA-I was replaced in Australia in the early 1970s by
another clone with chromosomal determinants for penicillinase
and resistance to tetracycline, kanamycin, neomycin, erythro-
mycin and mercury [5–7]. MLST and SCCmec typing of isolates
collected in two Melbourne hospitals in the 1970s have shownious Diseases. Published by Elsevier Ltd. All rights reserved
CMI Nimmo et al. Recombinant MRSA clone from the 1970s 445that a second multiresistant clone, ST2249-MRSA-III, a previ-
ously unrecorded member of clonal complex (CC) 45, was also
present in Melbourne hospitals at least from 1973 to 1979 [2–7].
When MLST loci are ordered by chromosomal position,
ST2249 and ST45 have identical alleles at ﬁve contiguous loci
(aroE-14, glpF-8, gmk-6, pta-10 and tpiA-3), whereas ST2249 and
ST239 have identical alleles at two contiguous loci (arcC-2 and
yqiL-3) that span the origin of replication (oriC) [4]. In addition,
ST2249 carries a type III SCCmec element, located downstream
of oriC and between arcC and yqiL, of the same type as that
carried by ST239. This arrangement suggests the possibility that
ST2249 arose as the result of a major chromosomal recombi-
nation involving parents that resemble ST45 and ST239. Of
note, ST239 is itself the result of a major chromosomal
recombination involving ST8-like and ST30-like parents [8].
Such recombinations between parents of distinct genetic
backgrounds that result in new multilocus sequence types are
unusual in S. aureus with only three reported to date [8,9]. The
aim of this study is to test the hypothesis that ST2249-MRSA-III
is a hybrid resulting from chromosomal recombination
involving ST45- and ST239-like parent strains.MethodsIsolates
Thirteen isolates belonging to ST2249-MRSA-III were available
from culture collections from two inner Melbourne teaching
hospitals from the 1970s (Table 1). Nine isolates from a chil-
dren’s teaching hospital had been studied previously [2,4,5].
Four additional isolates were obtained from a collection from
an adult teaching hospital.
DNA microarray analysis
Arrays and reagents were obtained from Alere Technologies
(Jena, Germany). The principle of the assay, related procedures
and a list of targets has been described previously [10]. TargetTABLE 1. Origin and dru type of ST2249 isolates
Isolate Year of isolation City Hospital dru type
SK1585 1973 Melbourne Children’s teaching dt11j
SK1814 1974 Melbourne Children’s teaching dt11j
SK1821 1974 Melbourne Children’s teaching dt11j
SK1696 1975 Melbourne Children’s teaching dt11j
AH1413 1976 Melbourne Adult teaching dt9aj
AH1414 1976 Melbourne Adult teaching dt9aj
AH1415 1976 Melbourne Adult teaching dt11j
AH1431 1976 Melbourne Adult teaching dt9aj
SK1582 1976 Melbourne Children’s teaching dt9aj
SK1717 1977 Melbourne Children’s teaching dt9aj
SK1774 1977 Melbourne Children’s teaching dt11j
SK1734 1978 Melbourne Children’s teaching dt9aj
SK1783 1979 Melbourne Children’s teaching dt9aj
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiologygenes included species markers, markers for accessory gene
regulator (agr) alleles and capsule types, virulence factors,
resistance genes, staphylococcal superantigen-like/exotoxin-like
genes (set/ssl genes) and genes encoding adhesion proteins and
immune evasion factors. Positive, negative and ambiguous re-
sults for individual markers including those requiring discrimi-
nation of allelic variants were interpreted as described
previously [11]. Our initial strategy was to examine microarray
results for available ST2249 isolates for evidence of likely
recombination and for diversity within the lineage.
dru PCR and coagulase typing
Sequencing of SCCmec direct repeat units (dru) of ten isolates
of ST2249 from 1973 to 1979 [4] was performed using the
forward (GTTAGCATATTACCTCTCCTTGC) and reverse
(GCCGATTGTGCTTGATGAG) primers described by Goer-
ing et al. [12] and the gel-based method described by Tohda
et al. [13]. Coagulase restriction fragment length polymorphism
was determined as previously described [14].
Genome sequencing and data analysis
Puriﬁed genomic DNA from ST2249 isolate SK1585, isolated in
1973 in Melbourne, was sheared to ~3 kb using a Covaris S220
focused ultrasonicator (Applied Biosystems, Woburn, MA,
USA). A Mate Pair library suitable for sequencing on the Ion-
Torrent PGM was prepared according to the manufacturer’s
instructions, and a single 318 chip of data was generated using
an Ion Torrent PGM (Life Technologies, Carlsbad, CA, USA)
according to the manufacturer’s instructions.
Reads were split into pairs with SFFEXTRACT 2.0.13, and ﬁle
headers were modiﬁed with in-house perl scripts before de
novo assembly with NEWBLER v2.6 (Roche, Branford, CT, USA).
Contigs were annotated with PROKKA v1.4 (Prokka: Prokaryotic
Genome Annotation System—http://vicbioinformatics.com/),
and scaffolds were ordered against S. aureus JKD6008 [15] using
MAUVE CONTIG MOVER TOOL [16]. The resulting set of ordered,
annotated scaffolds was deposited in GenBank
(AYLT00000000), and all raw data were organized under NCBI
bio-project PRJNA178070.
Identiﬁcation of major recombination breakpoints
The recombinant structure of the ST2249 chromosome was
characterized with two separate analyses. The publicly available
genome sequences of S. aureus strains JKD6008 and BK21252
were used as examples of ST2249’s putative parents, ST239 and
ST45, respectively (accession numbers NC_017341 and NZ_
AHJV00000000.1, respectively). Based on MAUVE analysis,
these two strains were closer in overall genome content to
ST2249 than other strains of similar sequence types with
publicly available genome sequences.and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 444–450
446 Clinical Microbiology and Infection, Volume 21 Number 5, May 2015 CMIThe ﬁrst analysis was based on the method of Brochet et al.
[17] Brieﬂy, the contigs of the draft genome sequence of
ST2249 were ordered using the genome coordinates of strain
JKD6008. The ST2249 genome sequence was then subdivided
into 500 bp, non-overlapping windows and subsequently
BLASTed against local databases of ST239 and ST45 genome
sequences. Only windows that produced a BLAST hit with
100% coverage and no gaps were considered. E-values of 10−2,
10−4 and 10−6 were considered but these identiﬁed the same
breakpoints, so 10−4 was selected for further analysis. Win-
dows with multiple hits to a parent and windows absent from
either of the two parents were discarded to ﬁlter out paralogs
and accessory regions, respectively. The number of nucleotide
polymorphisms within eligible windows, between ST2249 and
each of its two parents, was plotted according to the ST2249
genome coordinates.
For the second analysis, the ST2249 genome sequence was
aligned with those of its two putative parents using the pro-
gressive MAUVE algorithm of MAUVE v2.3.1 [18], with default
parameters. Locally collinear blocks were included in the sub-
sequent analysis provided that they contained sequence from all
three strains. Locally collinear blocks were ordered based on
the genome coordinates of strain JKD6008 and then concate-
nated. All gapped positions were removed. A sliding window
analysis was performed using DNASP v5 [19] to determine the
number of nucleotide polymorphisms between ST2249 and
each of its two parents, using 500 bp, non-overlapping win-
dows, and plotting these polymorphisms according to the
ST2249 genome coordinates.
Once the approximate breakpoint coordinates were deter-
mined, precise coordinates were identiﬁed through visual in-
spection of the sequences. The gene sequences that contained
the two major recombination breakpoints were then aligned
using the CLUSTALW algorithm, implemented in MEGALIGN v7.1
(Lasergene, DNAStar, Madison, WI, USA).Results and discussionMicroarray analysis of genomic DNA of 13 ST2249 isolates
showed general similarities with CC45/agr IV for most genomic
markers (Table 2, Fig. 1, and see Supporting information
Table S1). “CC45/agr IV” refers to a lineage within CC45 that
differs from the better known, more common and more
widespread “CC45/agr I” lineage to which, among others,
MRSA strains Berlin Epidemic Strain, USA 600, WA-MRSA 4
and WA- MRSA 106 belong. Differences between the two
CC45 lineages include not only the agr group afﬁliation but also
alleles of fnbA/B, sdrD, vwb and lmrP as well as the presence of
sasG. CC45/agr IV MRSA became common in Australia (WA-Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and InfectMRSA-23 and -84) and Hong Kong [11] but there are no data
on the distribution of CC45/agr IV in the 1970s when ST2249
emerged nor on CC45/agr IV-methicillin-susceptible S. aureus
(MSSA) in general.
However, several genes in ST2249 yielded microarray signals
that were not in accordance with CC45/agr IV alleles but rather
with CC8 alleles (sasG and fnbA/B, sdrC/D, ssl/set-locus) whereas
others matched hybridization patterns from CC30 (clfB, lmrP,
capsule locus) (Table 2). The MLST gene arcC had a CC30 and
ST239 sequence, whereas yqiL was identical to the sequence
from CC8 and ST239. The spa type was identical to that of
ST239 (t037). In addition, coagulase restriction fragment length
polymorphism PCR revealed the same type as AUS-2 and AUS-
3 strains, both Australian variants of ST239-MRSA-III [20].
Isolates of ST2249 collected over 7 years belonged to two
closely related dru types, 11j (six isolates from 1973 to 1977) or
9aj (seven isolates from 1976 to 1979) (Table 1). By array hy-
bridization, the SCCmec element was identiﬁed as type III, and
the presence of ccrC and the mercury resistance operon
resembled AUS-3.
Assuming a constant order of genes within any S. aureus
chromosome, these observations were in accordance with a
larger fragment of CC8 origin having been inserted into a
CC45/agr IV chromosome and a smaller fragment of CC30
origin around oriC having been inserted into that larger CC8
fragment. Because of the gene content similarities identiﬁed
through microarray analysis, as well as similarities identiﬁed by
MLST, spa, coagulase, dru and SCCmec typing, it was assumed
that the entire insert into the CC45/agr IV chromosome orig-
inated from an ST239-MRSA-III strain that itself originated from
a previously characterized recombination involving CC8 and
CC30.
To test this hypothesis and to more precisely characterize
the genome of ST2249, one isolate, SK1585, was sequenced.
Ion Torrent PGM sequencing generated 1699425 read pairs
(average length 90 bp). De novo assembly with NEWBLER resulted
in ~150 contigs that were further organized into 15 scaffolds
with an N50 = 456 855 bp, and an Nmax = 1 154 088 bp.
Recombination breakpoints were visually detected by
examining the changing pattern of nucleotide polymorphism in
the ST2249 genome sequence, in comparison with the ST239
and ST45 genomes (Fig. 2). Across the origin of replication, the
ST2249 chromosome is much more similar to the ST239
chromosome (ST2249 versus ST239: 0.0000872 nucleotide
polymorphisms/site) than to the ST45 chromosome (ST2249
versus ST45: 0.0175 nucleotide polymorphisms/site). However,
across the remainder of the chromosome, ST2249 is much
more similar to the ST45 chromosome (ST2249 versus ST45:
0.00012 nucleotide polymorphisms/site) than to the ST239
chromosome (ST2249 versus ST239: 0.014865 nucleotideious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 444–450
TABLE 2. Summary of the major differences between ST2249-MRSA-III, ST239-MRSA-III, CC8, CC30, CC45 (agrI) and CC45
(agrIV) by microarray analysis
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 444–450
FIG. 1. Approximate localization of
array targets in ST2249-MRSA-III
isolate SK1585 matching with targets
found in CC8, CC30 and CC45/agr
IV (outer circle) in comparison with
ST239 chromosome (inner circle).
448 Clinical Microbiology and Infection, Volume 21 Number 5, May 2015 CMIpolymorphisms/site) (Fig. 2). The above analysis was based on
BLASTN comparisons of genome sequences. Essentially the
same overall pattern of similarity between ST2249 and the
parent-like genomes of ST239 and ST45 was found using a
MAUVE alignment of genome sequences (see Supporting infor-
mation, Fig. S1).
The genomic comparisons identiﬁed recombination break-
points to the right and left of the origin of replication, which were
investigated in more detail. The right recombination breakpointFIG. 2. Comparison of single nucleotide polymorphisms (SNP) per site
of ST2249-MRSA-III (SK1585) with putative parents ST45 and ST239,
respectively.
Clinical Microbiology and Infection © 2015 European Society of Clinical Microbiology and Infectoccurs between sites 1014 and 1065 of the ST2249 gene
D484_00045 (Fig. 3). BLASTP searches indicate that this gene
encodes a putative poly(glycerol-phosphate) α-glucosyltransfer-
ase. The left recombination breakpoint occurs between sites 1185
and 1248 of the ST2249 gene D484_01632 (Fig. 3). BLASTP
searches indicate that this gene encodes nasD, which is a nitrate
reductase. Both recombination breakpoints occurred within the
coding sequences of the indicated genes, and the recombinations
did not introduce frameshift mutations into these genes. Neither
of these genes are the breakpoints of the previously identiﬁed
ST239, ST34 and ST42 hybrids of S. aureus [8,9].
These two recombination breakpoints indicate that ST2249
inherited approximately 981.5 kb (35.3%) of its chromosome
from an ST239-like parent, i.e. a CC8/CC30 hybrid strain itself,
and approximately 1798 kb (65.7%) from a CC45/agr IV-like
parent. These sizes are estimated from the draft genome
sequence of the ST2249 strain, SK1585. Minor uncertainties in
the exact size of the parental contributions arise from potential
sequencing/assembly errors, the undeﬁned location of one
scaffold that comprises ribosomal DNA operon that can be
found at multiple locations across S. aureus genomes, and the
possibility that ST2249 subsequently acquired or lost genes
(described below). We have shown that ST2249-MRSA-III most
probably resulted from a major recombination between par-
ents that resemble ST239-MRSA-III and CC45/agr IV, although a
recombination involving ST239-MSSA and CC45/agr IVious Diseases. Published by Elsevier Ltd. All rights reserved, CMI, 21, 444–450
FIG. 3. Right recombination breakpoint between sites 1014 and 1065 of the ST2249 gene D484_00045 and left recombination breakpoint between
sites 1185 and 1248 of the ST2249 gene D484_01632.
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element might have been possible. However, this possibility
seems unlikely as ST239-MSSA is very rare and ST2249-MSSA
has never been described.
ST2249 isolates have some unique gene content variations.
The gene bbp (bone binding protein) that is normally located
near the right recombination breakpoint was absent from the
draft genome sequence of strain SK1585 and it was not
detected by array hybridization in that strain. However, bbp
was present in 12 of 13 ST2249 isolates, suggesting that it has
been lost in some isolates and is not related to the major
recombination event. MAUVE misaligned a phiSa3-like phage with
phiNM3 and phiSa2-like phage, which is visible as a spike of
ST45 SNPs in the middle of the genome in Fig. S1 (see Sup-
porting information).
Although only limited Australian archival material is available,
the oldest extant isolate of ST2249 predates the oldest
Australian isolate of ST239 by 3 years [4]. Even older isolates of
ST239 are known from Europe [21]. It is therefore plausible
that these two recombinant clones were introduced into
Australia separately, or that ST2249 emerged in Australia
before the importation and spread of ST239 there was noted.
While comprehensive data are lacking, the parent CC45/agr IV
lineage appears to be more common in Asia than in either
Europe or North America, where it is virtually unknown (with
CC45/agr I being dominant), so suggesting a possible origin for
ST2249.
Another unanswered question is the mechanism by which
such large portions of the chromosome are transferred. It is
remarkable that transfer involves both core and accessory re-
gions of the chromosome as a block of contiguous DNA, and
that the recombination breakpoints can fall within genes
without introducing frameshifts: these characteristics are
consistent with homologous recombination. A high-frequency
of recombination (Hfr-like) conjugative process remains the
most likely mechanism of transfer, because of the large sizes of
the transferred DNA. Recent work on patterns ofClinical Microbiology and Infection © 2015 European Society of Clinical Microbiologyrecombination in the S. aureus chromosome has presented
evidence of elevated recombination rates around the origin of
replication and an association of localized recombination hot-
spots with integration sites of certain mobile genetic elements
[22]. Whether or not megabase-scale and kilobase-scale
recombination events are mediated through the same mecha-
nisms of transfer is unknown. Furthermore, it is possible that
more hybrid strains of S. aureus remain to be discovered. To
date, hybrid strains have been identiﬁed based on alleles from
MLST, spa and other strain-typing schemes that are at odds
with the rest of the strain’s typing proﬁle. Contemporary assays
such as array hybridization and full genome sequencing might
identify more hybrid strains, by interrogating at higher resolu-
tion across the entire genome.
Hence the frequency and causation of such events remains at
issue. As mentioned above, only three strains have been proven
to originate from genomic replacements, giving the impression
that megabase-scale recombinations are very rare events in the
evolution of S. aureus. It is therefore all the more intriguing that
ST2249 was derived from two major and temporally sequential
chromosomal recombinations (CC8 and CC30 to ST239; and
ST239 and CC45/agrIV to ST2249). If these events are indeed
rare and result from uncommon environmental conditions, it is
remarkable that they occurred twice in the formation of
ST2249.Transparency declarationSM and RE are employed by Alere Technologies GmbH.AcknowledgementsWe thank Neville Firth and Ron Skurray for provision of his-
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